Navigation Links
Janssen, J&J Innovation, VIB, KU Leuven and UZ Leuven join forces to combat neurological diseases
Date:5/29/2013

Stellar, the collaboration between Janssen, J&J Innovation, VIB, KU Leuven and UZ Leuven, is launched to overcome the inefficiencies in translating basic molecular insights to diagnostics and therapeutics for neurodegenerative diseases. Janssen and Johnson & Johnson Innovation are committing up to 5 million Euros for this project over a five-year period. They will sponsor academic research projects from VIB, KU Leuven and UZ Leuven.

"Developing a new drug takes lots of time, especially for complex diseases such as Alzheimer's. We are convinced that we can increase the chance of success if we, as a research institute, join forces with a pharmaceutical company like Janssen," Johan Cardoen (Managing Director VIB).

"At Janssen Research & Development, we are deeply committed to patients with neurodegenerative diseases and to the health care professionals who care for them," said Husseini Manji, MD, Global Head, Neuroscience. "We believe that collaboration with external innovators is essential to drive the types of discoveries that will bring forth the treatments of tomorrow for neurodegenerative diseases."

"At Johnson & Johnson Innovation, accelerating the most promising early-stage science in collaboration with leading academic centres around the world is how we will continue to make improvements in the health and happiness of people worldwide," commented Patrick Verheyen, head of the Johnson & Johnson Innovation centre in London.

Stellar: joining forces to combat neurological diseases

This innovative collaboration will address the funding gap in Flanders for translational projects and will result in relevant neuroprotective therapeutic strategies by enabling multidisciplinary research projects between basic molecular neuroscientists, experts in cognitive animal model testing, clinical neurologists, human imaging specialists and Janssen R&D scientists.

Stellar seeks to attract top researchers in the BeNeLux scientific community to submit proposals for cutting-edge research in neurodegenerative disorders. The Johnson & Johnson companies will collaborate initially with VIB, KU Leuven and The University Hospital Leuven to create opportunities for collaborative research. Other academic institutions are encouraged to join the project as its next phase begins later this year.

For more information about the initiative and the submission process, please visit http://www.stellar-project.be (available on June 17, 2013).


'/>"/>

Contact: Sooike Stoops
sooike.stoops@vib.be
32-924-46611
VIB (the Flanders Institute for Biotechnology)
Source:Eurekalert

Related biology news :

1. Science, Innovation, and Partnerships for Sustainability -- Symposium May 16-18
2. KU Leuven lab coordinates €9m effort to find new deep-sea drugs
3. UC Berkeley, UCSF and Stanford join forces to help commercialize university innovations
4. Molecular forces are key to proper cell division
5. NJIT and Chinese Tech Institute join forces for 2013 Solar Decathlon in China
6. Scientists join forces to bring plant movement to light
7. Social factors trump genetic forces in forging friendships, CU-led study finds
8. Eurofins MWG Operon reinforces NGS capability with Illumina HiSeq 2500 and Illumina MiSeq
9. New forensic institute at the University of Leicester will help police forces solve unusual crimes
10. University of Leeds and Chinese Academy of Sciences join forces
11. Scientists join forces in call for action to save coral reefs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/13/2017)... 2017 UBM,s Advanced Design and Manufacturing event ... emerging and evolving technology through its 3D Printing and ... alongside the expo portion of the event and feature ... focused on trending topics within 3D printing and smart ... event will take place June 13-15, 2017 at the Jacob ...
(Date:4/11/2017)... NXT-ID, Inc. (NASDAQ:   NXTD ) ("NXT-ID" or ... independent Directors Mr. Robin D. Richards and Mr. ... the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive Officer said," ... and benefiting from their considerable expertise as we move forward ...
(Date:4/4/2017)... 4, 2017   EyeLock LLC , a leader ... United States Patent and Trademark Office (USPTO) has issued ... linking of an iris image with a face image ... the company,s 45 th issued patent. ... timely given the multi-modal biometric capabilities that have recently ...
Breaking Biology News(10 mins):
(Date:9/21/2017)... ... September 21, 2017 , ... Executives ... the world’s most progressive pharma and biotech organizations to do more clinical trials ... and biotech events in Q4. , DrugDev will demonstrate DrugDev Spark™, the world’s ...
(Date:9/21/2017)... SAN DIEGO, CALIF. (PRWEB) , ... September 21, 2017 , ... ... kitchen earlier this month. The organization, a worldwide society of professional women with ... a venue to hold its annual dinner. , Twelve members began with ...
(Date:9/20/2017)... ... September 20, 2017 , ... Cybrexa Therapeutics , a ... the role of chief scientific officer. In this role, Dr. Paralkar will lead ... and CEO, Per Hellsund. , “I was impressed with Cybrexa’s revolutionary technology and ...
(Date:9/20/2017)... ... September 20, 2017 , ... Proscia ... Pathology , a provider of whole slide imaging solutions, are hosting a pre-conference ... workshop, entitled “Successfully Deploying a Best-in-Class Strategy for Digital Pathology,” will feature Proscia ...
Breaking Biology Technology: